AOAAM Enduring Half and Half Waiver Training 2022-Module 3: Clinical Management

Module 3: Clinical Management

Pdf Summary

This document is a training module on clinical management for waiver eligibility. It provides objectives such as listing topics to address during follow-up medication for addiction treatment (MAT) visits, describing key elements of clinical documentation, describing key elements of record-keeping practices, and describing strategies to support recovery. The module emphasizes the importance of using supportive and empathetic language, as stigmatizing language can adversely affect treatment outcomes. The document also covers various aspects of clinical documentation, including risk assessment and management, compliance with federal confidentiality regulations, and storage of records. It highlights the requirements and regulations set by the Drug Enforcement Agency (DEA) for buprenorphine prescription and the storage and dispensation of medications. The module also emphasizes the importance of supporting recovery through good prescribing and monitoring techniques, patient-centered care, and the use of community resources. It compares treatment adherence to other chronic conditions and provides recommendations for clinic policies and clear guidelines. The module concludes with an appendix on privacy protections and federal confidentiality regulations for alcohol and drug addiction treatment records.

Keywords

clinical management

waiver eligibility

MAT visits

clinical documentation

record-keeping practices

supportive language

treatment outcomes

federal confidentiality regulations

buprenorphine prescription

patient-centered care